|
| 36848245 | MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells. | | 2023 |
| 36108710 | Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma. | Gastroenterology | 2023 |
| 36037274 | Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH. | Hepatology | 2023 |
| 35943116 | TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis. | Cancer Medicine | 2023 |
| 36052732 | Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers. | Hepatology | 2023 |
| 38045348 | Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy. | | 2023 |
| 37944087 | Africa Guidelines for Hepatocellular Carcinoma Buildup Process. | | 2023 |
| 37561981 | The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. | JCO Precis Oncol | 2023 |
| 37874245 | Mendelian Randomization in hepatology: A review of principles, opportunities, and challenges. | | 2023 |
| 37337470 | Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. | | 2023 |
| 36899911 | The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth. | | 2023 |
| 37144952 | Opportunities to address gaps in early detection and improve outcomes of liver cancer. | | 2023 |
| 36765798 | Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States. | | 2023 |
| 37204402 | Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study. | | 2023 |
| 36890858 | Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma. | Cancer Res Commun | 2023 |
| 36877687 | Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV. | PLoS One | 2023 |
| 36943385 | Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortality. | | 2023 |
| 37313455 | Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses. | | 2023 |
| 36940423 | CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation. | Am J Gastroenterol | 2023 |
| 36691969 | Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC. | | 2023 |
| 37369012 | Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes. | Hum Mol Genet | 2023 |
| 37112976 | Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. | | 2023 |
| 37429366 | Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. | Gastroenterology | 2023 |
| 37297935 | Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography. | | 2023 |
| 36534786 | Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. | Cancer Prev Res (Phila) | 2023 |
| 37353797 | Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). | J Transl Med | 2023 |
| 37040087 | Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. | J Natl Cancer Inst | 2023 |
| 36599136 | Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. | Am J Gastroenterol | 2023 |
| 37524649 | Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection. | | 2023 |
| 37350981 | Diagnostic Performance of Greyscale Ultrasound in Detecting Fatty Liver Disease in a Type 2 Diabetes Population Using FibroScan as the Reference Standard. | | 2023 |
| 37036707 | Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America. | | 2023 |
| 34871554 | Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis. | Gastrointestinal Endoscopy | 2022 |
| 36111416 | Gaps in hepatocellular carcinoma surveillance in a United States cohort of insured patients with cirrhosis. | Current Medical Research and Opinion | 2022 |
| 35528972 | A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma. | Journal of Clinical and Translational Hepatology | 2022 |
| 36178256 | Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States. | Hepatology Communications | 2022 |
| 36099308 | Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival. | PLoS ONE | 2022 |
| 35961698 | Understanding the genetic basis for cholangiocarcinoma. | | 2022 |
| 36291862 | Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27. | Cancers | 2022 |
| 35565248 | Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma. | Cancers (Basel) | 2022 |
| 36000989 | Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma. | Clinical and Translational Gastroenterology | 2022 |
| 35429171 | Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States. | Hepatology | 2022 |
| 35997126 | Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States. | Cancer | 2022 |
| 35726905 | Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana. | Oncologist | 2022 |
| 35853191 | Untreated Chronic Hepatitis B Is Associated With a Higher Risk of Extrahepatic Malignancies. | Journal of Clinical Oncology | 2022 |
| 35349735 | Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes. | Hepatology | 2022 |
| 36419017 | A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021. | BMC Public Health | 2022 |
| 36188718 | High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence. | | 2022 |
| 35600358 | RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality? | Frontiers in Oncology | 2022 |
| 34407567 | Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers. | Hepatology | 2022 |
| 35333776 | Large Hepatic Adenomas and Hepatic Adenomatosis: A Multicenter Study of Risk Factors, Interventions, and Complications. | American Journal of Gastroenterology | 2022 |